1. ORMDL in metabolic health and disease
   Ryan D.R. Brown et al, 2023, Pharmacology & Therapeutics CrossRef
2. Diversity of sphingoid bases
   Thorsten Hornemann, 2024, Atherosclerosis CrossRef
3. Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis
   J. Jose Corbalan et al, 2024, Journal of Lipid Research CrossRef
4. Sex Differences in the Association Between AST/ALT and Incidence of Type 2 Diabetes in Japanese Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Cohort Study
   Cong Zhang et al, 2024, Endocrine Research CrossRef
5. Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis
   Jivani M. Gengatharan et al, 2024, Cell Metabolism CrossRef
6. Diagnostic value of triglyceride–glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study
   Rong Yu et al, 2023, BMJ Open CrossRef
7. Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model
   Xin-Yu Ge et al, 2023, Frontiers in Oncology CrossRef